Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
出版年份 2019 全文链接
标题
Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
作者
关键词
-
出版物
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Volume 90, Issue 6, Pages -
出版商
Wiley
发表日期
2019-08-26
DOI
10.1111/sji.12818
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Role of TLR4 Asp299Gly and TLR4 Thr399Ile Polymorphisms in the Pathogenesis of Urinary Tract Infections: First Evaluation in Infants and Children of Greek Origin
- (2019) Panagiota Karananou et al. Journal of Immunology Research
- Differential responses of epithelial cells from urinary and biliary tract to eggs of Schistosoma haematobium and S. mansoni
- (2019) Rafael Nacif-Pimenta et al. Scientific Reports
- HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
- (2018) Tristan A Barnes et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
- (2018) Nataša Obermajer et al. Nature Protocols
- Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
- (2018) Dharmesh Gopalakrishnan et al. Therapeutics and Clinical Risk Management
- TLR-3 Stimulation Skews M2 Macrophages to M1 Through IFN-αβ Signaling and Restricts Tumor Progression
- (2018) Aurobind Vidyarthi et al. Frontiers in Immunology
- Bladder Cancer: New Insights into Its Molecular Pathology
- (2018) Kentaro Inamura Cancers
- TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG
- (2018) Zhi-Jun Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Schistosomiasis
- (2018) Richard Barnett LANCET
- Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
- (2018) Elisabeth Müller et al. Frontiers in Immunology
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy
- (2017) Yang‐Min Ning et al. ONCOLOGIST
- Nivolumab Gets FDA Nod for Bladder Cancer
- (2017) Cancer Discovery
- The role of toll-like receptor 4 in tumor microenvironment
- (2017) Jing Li et al. Oncotarget
- A new model of self-resolving leptospirosis in mice infected with a strain of Leptospira interrogans serovar Autumnalis harboring LPS signaling only through TLR4
- (2017) Bili Xia et al. Emerging Microbes & Infections
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- TLR7 Deficiency Leads to TLR8 Compensative Regulation of Immune Response against JEV in Mice
- (2017) Muhammad Awais et al. Frontiers in Immunology
- Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
- (2017) Elisabeth Müller et al. Frontiers in Immunology
- Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
- (2017) Thomas Powles et al. JAMA Oncology
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier
- (2016) Patrick Vianna Garcia et al. BMC CANCER
- Double-Stranded RNA Interacts With Toll-Like Receptor 3 in Driving the Acute Inflammatory Response Following Lung Contusion
- (2016) Madathilparambil V. Suresh et al. CRITICAL CARE MEDICINE
- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
- (2016) Peter A. Humphrey et al. EUROPEAN UROLOGY
- Future directions in bladder cancer immunotherapy: towards adaptive immunity
- (2016) Sean G Smith et al. Immunotherapy
- CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro
- (2016) Weiguang Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer
- (2016) Renate Pichler et al. Oncotarget
- Toll-like Receptor 9 Can be Activated by Endogenous Mitochondrial DNA to Induce Podocyte Apoptosis
- (2016) Wenduona Bao et al. Scientific Reports
- Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer
- (2015) Maria João Gouveia et al. CANCER LETTERS
- Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise
- (2015) J. Kim et al. CLINICAL CANCER RESEARCH
- Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder
- (2015) Philip H. Kim et al. EUROPEAN UROLOGY
- Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?
- (2015) Srinath Sundararajan et al. Future Oncology
- Nivolumab: targeting PD-1 to bolster antitumor immunity
- (2015) Julie R Brahmer et al. Future Oncology
- Molecular Biology of Bladder Cancer
- (2015) William Martin-Doyle et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility
- (2015) Mamoona Noreen et al. IMMUNOLOGIC RESEARCH
- Imiquimod - Its role in the treatment of cutaneous malignancies
- (2015) AdityaKumar Bubna INDIAN JOURNAL OF PHARMACOLOGY
- Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation
- (2015) Dah-Shyong Yu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Toll-like receptor agonist lipopeptides self-assemble into distinct nanostructures
- (2014) Ian W. Hamley et al. CHEMICAL COMMUNICATIONS
- RNA and Imidazoquinolines Are Sensed by Distinct TLR7/8 Ectodomain Sites Resulting in Functionally Disparate Signaling Events
- (2014) E. Colak et al. JOURNAL OF IMMUNOLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Tumor-Associated Macrophages as a Paradigm of Macrophage Plasticity, Diversity, and Polarization
- (2013) Alberto Mantovani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
- (2013) C. Gao et al. CANCER RESEARCH
- T-cell tolerance in cancer
- (2013) Roza Nurieva et al. Immunotherapy
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update
- (2013) Francesco Peri et al. JOURNAL OF MEDICINAL CHEMISTRY
- From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa
- (2013) M A Ingersoll et al. Mucosal Immunology
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Toll-like receptors in urothelial cells—targets for cancer immunotherapy
- (2013) Hélène LaRue et al. Nature Reviews Urology
- The Herpes Simplex Virus 1-Encoded Envelope Glycoprotein B Activates NF-κB through the Toll-Like Receptor 2 and MyD88/TRAF6-Dependent Signaling Pathway
- (2013) Mingsheng Cai et al. PLoS One
- Single-nucleotide Polymorphisms in Genes Encoding Toll-like Receptor -2, -3, -4, and -9 in a Case–Control Study with Bladder Cancer Susceptibility in a North Indian Population
- (2012) Vibha Singh et al. ARCHIVES OF MEDICAL RESEARCH
- Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
- (2012) Shaherin Basith et al. ARCHIVES OF PHARMACAL RESEARCH
- Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis
- (2012) Baerin B. Houghton et al. BJU INTERNATIONAL
- The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
- (2012) R. J. deLeeuw et al. CLINICAL CANCER RESEARCH
- The application of Toll like receptors for cancer therapy
- (2012) Eui Young So et al. International Journal of Biological Sciences
- U1-Small Nuclear Ribonucleoprotein Activates the NLRP3 Inflammasome in Human Monocytes
- (2012) M. S. Shin et al. JOURNAL OF IMMUNOLOGY
- Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer
- (2012) Johannes Falke et al. JOURNAL OF UROLOGY
- Toll-like Receptor 4 Gene Polymorphisms and Susceptibility to Bladder Cancer
- (2012) Yizhen Shen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prognostic Value of Cell-Cycle Regulation Biomarkers in Bladder Cancer
- (2012) Anirban P. Mitra et al. SEMINARS IN ONCOLOGY
- Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities
- (2012) David W. Chang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells
- (2012) Yong-Gang Li et al. Virology Journal
- HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response
- (2011) Gaia Codolo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- A delicate dance: host response to mycobacteria
- (2011) Kassidy K Huynh et al. CURRENT OPINION IN IMMUNOLOGY
- 179 A PRECLINICAL PLACEBO CONTROLLED EFFICACY STUDY WITH R-837 AND TMX-202 IN AN ORTHOTOPIC RAT BLADDER CANCER MODEL
- (2011) J. Falke et al. EUROPEAN UROLOGY SUPPLEMENTS
- TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated
- (2011) Hamid Akbarshahi et al. Journal of Translational Medicine
- Toll-Like Receptors in Normal and Malignant Human Bladders
- (2011) Cherifa Ayari et al. JOURNAL OF UROLOGY
- Toll-Like Receptor Responses of Normal Human Urothelial Cells to Bacterial Flagellin and Lipopolysaccharide
- (2011) Nicholas J. Smith et al. JOURNAL OF UROLOGY
- Immunolocalization of Toll-Like Receptors 2 and 4 as well as Their Endogenous Ligand, Heat Shock Protein 70, in Rat Traumatic Brain Injury
- (2011) Zhiren Zhang et al. NEUROIMMUNOMODULATION
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
- (2011) Ilyar Sheyhidin WORLD JOURNAL OF GASTROENTEROLOGY
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma
- (2010) L K Ng et al. BRITISH JOURNAL OF CANCER
- Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- (2010) Salomé González-Reyes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome
- (2010) David Lindgren et al. CANCER RESEARCH
- Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
- (2010) B. C. Carthon et al. CLINICAL CANCER RESEARCH
- Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression
- (2010) Martin Grimm et al. EUROPEAN JOURNAL OF CANCER
- Intravesical Toll-like receptor 7 agonist R-837: Optimization of its formulation in an orthotopic mouse model of bladder cancer
- (2010) Tomoko Hayashi et al. INTERNATIONAL JOURNAL OF UROLOGY
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
- (2010) Masahiro Azuma et al. PLoS One
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- CpG Oligodeoxyneucleotides as TLR9 Agonists
- (2009) Yanal M. Murad et al. BIODRUGS
- Toll-like receptor expression in normal ovary and ovarian tumors
- (2009) Mingfu Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Toll-like receptor agonists in cancer therapy
- (2009) Sylvia Adams Immunotherapy
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Requirement for DNA CpG Content in TLR9-Dependent Dendritic Cell Activation Induced by DNA-Containing Immune Complexes
- (2009) K. Yasuda et al. JOURNAL OF IMMUNOLOGY
- CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity
- (2009) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women
- (2009) Thomas R. Hawn et al. PLoS One
- Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women
- (2009) Thomas R. Hawn et al. PLoS One
- TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells
- (2008) Yigang Qian et al. CANCER INVESTIGATION
- Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors
- (2008) Masashi Murata CANCER SCIENCE
- TLR-mediated immune responses in the urinary tract
- (2008) Jeongmin Song et al. CURRENT OPINION IN MICROBIOLOGY
- Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer
- (2008) Marc Colombel et al. EUROPEAN UROLOGY SUPPLEMENTS
- Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent
- (2008) Alvaro Morales EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling
- (2008) Yigang Qian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Increased expression of Toll-like receptors 4 and 9 in human lung cancer
- (2008) Yan-Bei Zhang et al. MOLECULAR BIOLOGY REPORTS
- Polymorphisms in Toll-like receptor genes and risk of cancer
- (2008) E M El-Omar et al. ONCOGENE
- Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response
- (2007) Patricia Méndez-Samperio et al. ARCHIVES OF MEDICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started